Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 7 of 7 entries
View as:

Oral AQX-1125 and Combination Oral Contraceptive Drug-Drug Interaction Study

Phase: N/A Priority: Normal
NCT ID: NCT03478020 Org: User:
Start: 11/22/17 End: 04/05/18 Due: 04/05/19

Phase 1 Absorption Distribution Metabolism and Excretion of AQX-1125

Phase: N/A Priority: Normal
NCT ID: NCT03185195 Org: User:
Start: 11/22/16 End: 01/04/17 Due: 01/04/18

Pilot Efficacy and Safety Study of AQX-1125 in Atopic Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT02324972 Org: User:
Start: 12/31/14 End: 12/31/15 Due: 12/31/16

Efficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT02858453 Org: User:
Start: 07/31/16 End: 02/29/20 Due: 02/28/21

Efficacy and Safety of AQX-1125 in Unstable COPD

Phase: N/A Priority: Normal
NCT ID: NCT01954628 Org: User:
Start: 10/31/13 End: 12/31/15 Due: 12/31/16

Efficacy and Safety of AQX-1125 in Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT03500159 Org: User:
Start: 04/18/18 End: 07/17/18 Due: 07/17/19

Efficacy and Safety of AQX-1125 in IC/BPS

Phase: N/A Priority: Normal
NCT ID: NCT01882543 Org: User:
Start: 06/30/13 End: 06/30/15 Due: 06/30/16